Original articleComparative genomic hybridization analysis identifies gains of 1p35∼p36 and chromosome 19 in osteosarcoma
Introduction
Osteosarcoma (OS) is the most common malignant tumor of bone occurring at a peak incidence in pediatric and early adult life (age 15–29) with a second incidence peak in later life (>60). The tumors exhibit karyotypes with a high degree of complexity that has made it difficult to determine if recurrent chromosomal aberrations characterize OS. Several reports using conventional cytogenetic analysis have revealed highly aneuploid karyotypes with complex structural rearrangements including ring chromosomes and double minute chromosomes 1, 2, 3, 4, 5, 6.
To address the inherent difficulties associated with classical cytogenetic analysis, comparative genomic hybridization (CGH) has been systematically applied to OS. There have been eight CGH studies of OS 7, 8, 9, 10, 11, 12, 13, 14 that have identified frequent chromosomal gains at 1q, 4q, 5p 7q, 8q, 14q, and losses at chromosomes 2q, 3p, 6q, 8p, 10p. Sites of high level gain or amplification have been identified at 8q23∼ q24, 12q12∼q13 and 17q11∼p12.
One of the sources of confusion in the cytogenetic and CGH OS literature has been that many studies have not distinguished between the early and later onset forms of OS. It is probable that the etiology of each form of OS is different and the pattern of chromosomal aberration observed likely reflects the differing disease processes in an age-dependent manner. Another complication is that many of the published studies have included tumors exposed to chemotherapy prior to cytogenetic or CGH analysis and cultured OS cell lines. Clearly many random and non-random aberrations may be treatment-induced or in vitro artifacts and may not be typical of OS.
In this study, we have analyzed 18 untreated tumors derived from 17 of the younger OS incidence age group by CGH and identified a pattern of recurrent gain of the region 1p35∼p36 and chromosome 19. For a subset of OS tumors we were able to determine the nature of structural chromosomal rearrangements leading to chromosomal gain by spectral karyotyping (SKY) analysis of metaphases and to confirm chromosomal gains as aneusomies by interphase FISH.
Section snippets
OS tumor specimens and cytogenetic preparation
Osteocarcinomas tumor samples #1–5 were obtained from Departamento de Morfolgia Disciplina de Genêtica (Sao Paulo, Brazil). Tumor samples #6–16 and #18 were obtained from Hospital for Sick Children (Toronto, Canada) and tumor sample #17 from British Columbia's Children's Hospital (Vancouver, Canada). These tumors were obtained from 10 males and 7 female patients with a mean age at diagnosis of 15.8 years (range of 9–21 years). Portions of all tumor specimens were snap frozen and stored in
Comparative genomic hybridization
Comparative genomic hybridization analysis of 18 tumors derived from 17 patients is summarized in Table 1. Tumor #9 was a metastatic sample derived from the same patient whose primary sample was tumor #8. The CGH results from both the primary and metastatic tumor samples were very similar. In Fig. 1, a summary of the CGH results of the OS tumors from the 17 patients is illustrated in the composite karyogram. Gains predominated over losses for all chromosomes except chromosomes 15 and 21, which
Discussion
OS has been particularly refractory to conventional chromosome analysis and only a limited number of cytogenetic studies comprising fewer than 200 OS tumors have been published 1, 2, 3, 4, 5, 6. Aberrations more commonly seen include aberrations of chromosomal bands or regions 1p11∼p13, 1q11∼q12, 1q21∼q22, 11p15, 12p13, 17p12∼p13, 19q13, and 22q11∼q13 and the most common numerical abnormalities are +1, −9, −10, −13, and −17 summarized in [6].
CGH has recently been used with some success to study
Acknowledgements
This work was supported by the National Cancer Institute of Canada, with funds from the Canadian Cancer Society.
References (30)
- et al.
Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes
Cancer Genet Cytogenet
(1994) - et al.
Presence of double minutes and monosomy 17p in xenografted human osteosarcomas
Cancer Genet Cytogenet
(1996) - et al.
Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature
Cancer Genet Cytogenet
(1997) - et al.
Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p
Cancer Genet Cytogenet
(2000) - et al.
Molecular cytogenetics of bone and soft tissue tumors
Cancer Genet Cytogenet
(1997) - et al.
Aberrations of chromosomes 1 and 17 in six human osteosarcoma cell lines using double-target fluorescence in situ hybridization
Cancer Genet Cytogenet
(1998) - et al.
Relationship between chromosomal aberrations by fluorescence in situ hybridization and DNA ploidy by cytofluorometry in osteosarcoma
Cancer Lett
(1999) - et al.
Gene fusions encoding chimaeric transcription factors in solid tumours
Semin Cancer Biol
(1996) - et al.
Chromosome analysis of nine osteosarcomas
Genes Chromosom Cancer
(1994) - et al.
Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors
Cytometry
(1996)
Cytogenetic findings in 35 osteosarcoma specimens and a review of the literature
Pediatr Pathol Mol Med
Comparative genomic hybridization of low-grade central osteosarcoma
Mod Pathol
Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15a combined cytogenetic and comparative genomic hybridization study
Genes Chromosom Cancer
Chromosomal regions involved in the pathogenesis of osteosarcomas
Genes Chromosom Cancer
Cited by (67)
Osteosarcoma and ATR-16 syndrome: Association or coincidence?
2015, Anales de PediatriaThe metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses
2013, Human PathologyMicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma
2013, Human PathologyA genome-wide approach to comparative oncology: High-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations
2012, Cancer GeneticsCitation Excerpt :This increased apparent genomic complexity, combined with the sheer number of microaberrations identified in both human and canine OS, further highlights the need for comparative analysis as a tool to enhance our understanding of the disease. This study found that the canine orthologous regions of human chromosomal segments with the most gains, HSA 1p36.32 (CFA 5q32), HSA 1q21.2–q22 (CFA 17q23–q24, 7q17, 38q15.2), HSA 6p22–p21 (CFA 2q11–q21.1), and HSA 8q24 (CFA 13q12.3–q21.2), all had similar frequencies of CNA to both previously reported human OS aCGH data (12–14,39–44) and our own aCGH evaluation of human OS (Figures 1, 3, and 5). These observations demonstrate that in addition to anatomical, physiological, and singular gene abnormalities, human and canine OS share orthologous regions of recurrent CNA at a genome-wide level.
MAPK7 and MAP2K4 as prognostic markers in osteosarcoma
2012, Human PathologyCitation Excerpt :We have used quantitative polymerase chain reaction (PCR) for gene expression investigation, and we have compared these genes expression with healthy bone samples. The genes of this study were selected, considering the regions with more frequent genomic gain reported in previous work [10]. Our objectives were to validate the increase in the gene expression related to the genomic gain using the technique of quantitative PCR and to correlate these values with the clinical data of patients with OS.
Cyclin E1 is amplified and overexpressed in osteosarcoma
2011, Journal of Molecular Diagnostics